Fierce Health Payers March 19, 2021
Glen Tullman led a blockbuster IPO when Livongo raised $335 million as it went public in 2019. He also was involved in one of the largest deals in digital health when Teladoc bought Livongo a year later for $18.5 billion.
But Tullman feels there’s more work to do in healthcare. With his latest venture, he’s aiming to overhaul the employer-sponsored benefits space.
“People joke that I don’t know when to quit,” Tullman told Fierce Healthcare.
Tullman launched the new company, Transcarent, with General Catalyst Managing Partner Hemant Taneja. General Catalyst also was a big investor in Livongo, a diabetes management company.
Under Tullman’s leadership, Livongo developed a data-science-driven chronic disease management solution and scaled up remote patient monitoring services. While...
Today's Sponsors
Today's Sponsor